Sponsor:
The Methodist Hospital Research Institute
Code:
NCT03971487
Conditions
Schizo-Affective Type of Psychosis
Schizophrenia
Eligibility Criteria
Sex: All
Age: 18 - 35
Healthy Volunteers: Not accepted
Interventions
Psychosis and cognitive assessments
Physical and neuro-cognitive evaluations
Safety labs and electrocardiogram
Ocrelizumab infusion
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by The Methodist Hospital Research Institute on 2024-02-07.